The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Paul H. Sugarbaker

Program in Peritoneal Surface Malignancy

Washington Cancer Institute

106 Irving Street

Northwest

USA. Electronic address:

[email]@medstar.net

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Program in Peritoneal Surface Malignancy, Washington Cancer Institute, 106 Irving Street, Northwest, USA. Electronic address:. 2003 - 2012
  • Washington Cancer Institute, Washington Hospital Center, 106 Irving St., NW, Suite 3900, USA. 2002 - 2010
  • Washington Cancer Institute, DC 20010, USA. 2001 - 2008

References

  1. Early intervention for treatment and prevention of colorectal carcinomatosis: a plan for individualized care. Sugarbaker, P.H. Surg. Oncol. Clin. N. Am. (2012) [Pubmed]
  2. Pont hepatique (hepatic bridge), an important anatomic structure in cytoreductive surgery. Sugarbaker, P.H. J. Surg. Oncol (2010) [Pubmed]
  3. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer. Sugarbaker, P.H. Curr. Opin. Obstet. Gynecol. (2009) [Pubmed]
  4. Epithelial appendiceal neoplasms. Sugarbaker, P.H. Cancer. J (2009) [Pubmed]
  5. Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: the Washington Cancer Institute approach. Sugarbaker, P.H. Expert. Opin. Pharmacother (2009) [Pubmed]
  6. Thin-walled cysts as a pathognomonic CT finding in cystic mesothelioma. Sugarbaker, P., Yan, T., Zappa, L., Haveric, N., Brun, E. Tumori (2008) [Pubmed]
  7. Circumferential cutaneous traction for exposure of the layers of the abdominal wall. Sugarbaker, P.H. J. Surg. Oncol (2008) [Pubmed]
  8. The porta hepatis as a site of recurrence of mucinous appendiceal neoplasms treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy. Sugarbaker, P.H., Bijelic, L. Tumori (2008) [Pubmed]
  9. Management of mucinous urachal neoplasm presenting as pseudomyxoma peritonei. Sugarbaker, P.H., Verghese, M., Yan, T.D., Brun, E. Tumori (2008) [Pubmed]
  10. Peritonectomy procedures. Sugarbaker, P.H. Cancer Treat. Res. (2007) [Pubmed]
  11. How safe and effective is surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei?. Sugarbaker, P.H. Nature Clinical Practice. Gastroenterology & Hepatology (2007) [Pubmed]
  12. Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy. Sugarbaker, P.H. Int. J. Hyperthermia (2007) [Pubmed]
  13. The approval process for hyperthermic intraoperative intraperitoneal chemotherapy. Sugarbaker, P.H., Clarke, L. Eur. J. Surg. Oncol (2006) [Pubmed]
  14. The natural history, gross pathology, and histopathology of appendiceal epithelial neoplasms. Sugarbaker, P.H. Eur. J. Surg. Oncol (2006) [Pubmed]
  15. Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C. Sugarbaker, P.H., Stuart, O.A., Carmignani, C.P. Cancer Chemother. Pharmacol. (2006) [Pubmed]
  16. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?. Sugarbaker, P.H. Lancet Oncol. (2006) [Pubmed]
  17. Hybrid ileostomy. Sugarbaker, P.H., Cabañas, J. J. Surg. Oncol (2006) [Pubmed]
  18. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Sugarbaker, P.H., Alderman, R., Edwards, G., Marquardt, C.E., Gushchin, V., Esquivel, J., Chang, D. Ann. Surg. Oncol. (2006) [Pubmed]
  19. Comprehensive management of diffuse malignant peritoneal mesothelioma. Sugarbaker, P.H., Yan, T.D., Stuart, O.A., Yoo, D. Eur. J. Surg. Oncol (2006) [Pubmed]
  20. Adjuvant intraperitoneal chemotherapy for advanced primary gastric cancer. Sugarbaker, P.H. Scand. J. Surg (2006) [Pubmed]
  21. Avoiding carcinogen exposure with intraperitoneal paclitaxel. Stuart, O.A., Knight, C., Sugarbaker, P.H. Oncol. Nurs. Forum (2005) [Pubmed]
  22. Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Harmon, R.L., Sugarbaker, P.H. Int. Semin. Surg. Oncol (2005) [Pubmed]
  23. Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy. Sugarbaker, P.H., Mora, J.T., Carmignani, P., Stuart, O.A., Yoo, D. Oncologist (2005) [Pubmed]
  24. Strategies for the prevention and treatment of peritoneal carcinomatosis from gastrointestinal cancer. Sugarbaker, P.H. Cancer Invest. (2005) [Pubmed]
  25. Colorectal carcinomatosis: a new oncologic frontier. Sugarbaker, P.H. Curr. Opin. Oncol (2005) [Pubmed]
  26. Peritoneal surface oncology: review of a personal experience with colorectal and appendiceal malignancy. Sugarbaker, P.H. Tech. Coloproctol (2005) [Pubmed]
  27. An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution. Sugarbaker, P.H. J. Surg. Oncol (2005) [Pubmed]
  28. Strategies for management of the peritoneal surface component of cancer: cytoreductive surgery plus perioperative intraperitoneal chemotherapy. Sugarbaker, P.H., Stuart, O.A., Yoo, D. J. Oncol. Pharm. Pract (2005) [Pubmed]
  29. A curative approach to peritoneal carcinomatosis from colorectal cancer. Sugarbaker, P.H. Semin. Oncol. (2005) [Pubmed]
  30. Managing the peritoneal surface component of gastrointestinal cancer. Part 1. Patterns of dissemination and treatment options. Sugarbaker, P.H. Oncology (Williston Park, N.Y.) (2004) [Pubmed]
  31. Carcinomatosis from gastrointestinal cancer. Sugarbaker, P.H. Ann. Med. (2004) [Pubmed]
  32. Managing the peritoneal surface component of gastrointestinal cancer. Part 2. Perioperative intraperitoneal chemotherapy. Sugarbaker, P.H. Oncology (Williston Park, N.Y.) (2004) [Pubmed]
  33. Transureteroureterostomy: an adjunct to the management of advanced primary and recurrent pelvic malignancy. Sugarbaker, P.H., Gutman, M., Verghese, M. Int. J. Colorectal. Dis (2003) [Pubmed]
  34. A review of peritoneal mesothelioma at the Washington Cancer Institute. Sugarbaker, P.H., Welch, L.S., Mohamed, F., Glehen, O. Surg. Oncol. Clin. N. Am. (2003) [Pubmed]
  35. Peritonectomy procedures. Sugarbaker, P.H. Surg. Oncol. Clin. N. Am. (2003) [Pubmed]
  36. Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer. Sugarbaker, P.H., Yu, W., Yonemura, Y. Semin. Surg. Oncol (2003) [Pubmed]
  37. Central venous access through the right gonadal vein. Sugarbaker, P.H. J. Surg. Oncol (2002) [Pubmed]
  38. Cytoreduction including total gastrectomy for pseudomyxoma peritonei. Sugarbaker, P.H. Br. J. Surg (2002) [Pubmed]
  39. The subpyloric space: an important surgical and radiologic feature in pseudomyxoma peritonei. Sugarbaker, P.H. Eur. J. Surg. Oncol (2002) [Pubmed]
  40. Cytoreductive surgery and perioperative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Sugarbaker, P.H. Tumori (2001) [Pubmed]
  41. Pedunculated peritoneal surface polyps in pseudomyxoma peritonei syndrome. Sugarbaker, P.H., Yan, H., Shmookler, B. Histopathology (2001) [Pubmed]
  42. Vertical abdominoplasty. Sugarbaker, P.H. J. Surg. Oncol (2001) [Pubmed]
 
WikiGenes - Universities